These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9543113)

  • 1. A little more on lipoprotein profile in peripheral arterial disease.
    Pedro-Botet J; Rubiés-Prat J; Sentí M
    Atherosclerosis; 1998 Feb; 136(2):403-4. PubMed ID: 9543113
    [No Abstract]   [Full Text] [Related]  

  • 2. Regarding "Lipoprotein (a) levels in peripheral atherosclerotic disease".
    Simoni G; Gianotti A
    J Vasc Surg; 1995 Dec; 22(6):813-5. PubMed ID: 8523620
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipoproteins and atherogenesis.
    Hoeg JM
    Endocrinol Metab Clin North Am; 1998 Sep; 27(3):569-84, viii. PubMed ID: 9785053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Novel risk factors for atherosclerosis. A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a) and cholesterol as predictors of peripheral arteriopathy].
    Iacoviello L; Donati MB; de Gaetano G
    Ital Heart J Suppl; 2001 Sep; 2(9):1031-3. PubMed ID: 11675827
    [No Abstract]   [Full Text] [Related]  

  • 5. Interaction of family history of atherosclerosis with atherogenic lipid traits in men with non-coronary atherosclerosis.
    Sentí M; Pedro-Botet J; Pavesi M; Marrugat J; Aubó C; Pena A; Martín S; Rubiés-Prat J
    Clin Chim Acta; 1997 Aug; 264(2):193-205. PubMed ID: 9293377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease.
    Ridker PM; Stampfer MJ; Rifai N
    JAMA; 2001 May; 285(19):2481-5. PubMed ID: 11368701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical risk factors for cardiovascular disease in an aged male population: emerging vascular pathogens.
    Lippi G; Arosio E; Prior M; Guidi G
    Angiology; 2001 Oct; 52(10):681-7. PubMed ID: 11666132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ["Sinking" lipoprotein].
    Avogaro P
    G Ital Cardiol; 1974; 4(6):651-4. PubMed ID: 4375066
    [No Abstract]   [Full Text] [Related]  

  • 9. [Value of the simultaneous determination of the beta-lipoprotein level and beta-lipoprotein and alpha-lipoprotein ratio in the detection of a tendency to arteriosclerosis. (Study of 110 patients)].
    DINELLI CA; MONTANI E; SALA E
    Resen Clin Cient; 1962 Jun; 31():151-4. PubMed ID: 13886472
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipoproteins: what, when, and how often to measure.
    Brown WV
    Heart Dis Stroke; 1992; 1(1):20-6. PubMed ID: 1344644
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes in the cholesterol-HDL fraction in experimental arteriosclerosis].
    Badimón JJ; Villaverde CA; Badimón L; Padró T; Valdecasas FG
    Arch Farmacol Toxicol; 1981 Apr; 7(1):109-12. PubMed ID: 7325698
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of lovastatin on high-density lipoprotein subfractions in hypercholesterolemic patients with peripheral vascular disease.
    Tilly-Kiesi M; Mattila SP; Tikkanen MJ
    Angiology; 1993 Feb; 44(2):129-37. PubMed ID: 8434806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lipoprotein (a) as a risk factor in the development of atherosclerosis].
    Liakishev AA; Pokrovskiĭ SN; Susekov AV
    Kardiologiia; 1991 Feb; 31(2):71-5. PubMed ID: 1828281
    [No Abstract]   [Full Text] [Related]  

  • 14. High-density lipoproteins and peripheral vascular disease in octo- and nonagenarians.
    Schneider J
    J Am Geriatr Soc; 1980 May; 28(5):215-9. PubMed ID: 7365184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of eicosanoids for arteriosclerosis and the effect of lipoproteins on prostanoid formation].
    Mest HJ; Beitz J
    Z Gesamte Inn Med; 1986 Feb; 41(4):94-8. PubMed ID: 3518258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipoproteins and arteriosclerosis].
    Shinomiya M; Morisaki N; Murano S; Sasaki N; Shirai K; Matsuoka N; Saito Y; Kumagai A
    Nihon Rinsho; 1980 Jul; 38(7):2798-814. PubMed ID: 7007691
    [No Abstract]   [Full Text] [Related]  

  • 17. On the relation between peripheral atherosclerosis and serum lipoproteins.
    Erikson U; Ericsson M; Persson R
    Ups J Med Sci; 1979; 84(1):95-104. PubMed ID: 220766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipoprotein (a) in arterial retinal vascular occlusions].
    Diekstall F; Canzler H; Schmidt E; Demeler U
    Fortschr Ophthalmol; 1987; 84(4):369-71. PubMed ID: 2959601
    [No Abstract]   [Full Text] [Related]  

  • 19. [Structure and metabolism of plasma lipoproteins: effect of atherosclerosis].
    Fellin R
    G Ital Cardiol; 1976; 6(5):961-7. PubMed ID: 188709
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombophilic risk factors for symptomatic peripheral arterial disease.
    Sofi F; Lari B; Rogolino A; Marcucci R; Pratesi G; Dorigo W; Pratesi C; Gensini GF; Abbate R; Prisco D
    J Vasc Surg; 2005 Feb; 41(2):255-60. PubMed ID: 15768007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.